Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-037693

Options or other derivatives

  • Director acquired 7,881 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ratcliffe Liam Director 2019-06-14 Grant or award · Stock Option (Right to Buy) +7,881 $1.67 $13,125 7,881 D
Loading xslF345X03/doc4.xml…